World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
49
Citations
8485
World Ranking
4575
National Ranking
142

Overview

Carlos Juan is affiliated with the University of the Balearic Islands in Spain. Their research primarily focuses on biochemistry, genetics, and molecular biology, with significant contributions in molecular medicine, molecular biology, endocrinology, pollution, and pulmonary and respiratory medicine.

Their work centers on topics related to antibiotic resistance in bacteria, bacterial biofilms and quorum sensing, pharmaceutical and antibiotic environmental impacts, Vibrio bacteria research studies, antimicrobial peptides and activities, antibiotics pharmacokinetics and efficacy, and infections and bacterial resistance.

Frequent coauthors of Carlos Juan include Antonio Oliver, María Escobar-Salom, Elena Jordana-Lluch, Isabel M. Barceló, and Gabriel Torrens.

They have published repeatedly in several scientific journals, with notable frequent publication venues being Microbiology Spectrum, Journal of Antimicrobial Chemotherapy, Scientific Reports, Antimicrobial Agents and Chemotherapy, and Infection.

Their recent papers include:

  • In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa (2020), Journal of Antimicrobial Chemotherapy
  • Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective (2024), Infection
  • Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones (2021), Journal of Antimicrobial Chemotherapy
  • 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics (2021), Journal of Medicinal Chemistry
  • Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa (2024), Journal of Antimicrobial Chemotherapy

Best Publications

  • The increasing threat of Pseudomonas aeruginosa high-risk clones.

    Antonio Oliver;Xavier Mulet;Carla López-Causapé;Carlos Juan

  • β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein

    Bartolomé Moya;Andreas Dötsch;Carlos Juan;Jesús Blázquez

  • Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals

    O. Gutiérrez;C. Juan;E. Cercenado;F. Navarro

  • Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones

    Gabriel Cabot;Alain A. Ocampo-Sosa;M. Angeles Domínguez;Juan F. Gago

  • Pseudomonas Aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC

    Gabriel Cabot;Sebastian Bruchmann;Xavier Mulet;Laura Zamorano

  • Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains

    Carlos Juan;María D. Maciá;Olivia Gutiérrez;Carmen Vidal

  • Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2

    Jesús Oteo;Karol Diestra;Carlos Juan;Verónica Bautista

  • Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem

    Elena Riera;Gabriel Cabot;Xavier Mulet;María García-Castillo

  • Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.

    Gabriel Cabot;Laura Zamorano;Bartolomé Moyà;Carlos Juan

  • Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues

    Carlos Juan;Bartolomé Moyá;José L. Pérez;Antonio Oliver

  • Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.

    Pablo A Fraile-Ribot;Gabriel Cabot;Xavier Mulet;Leonor Periañez

  • Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.

    Carlos Juan;Carmen Peña;Antonio Oliver

  • Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections

    Antonio Oliver;Bruce R. Levin;Carlos Juan;Fernando Baquero

  • Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities

    Bartolomé Moyá;Alejandro Beceiro;Gabriel Cabot;Carlos Juan

  • Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients

    Bartolome Moya;Laura Zamorano;Carlos Juan;José L. Pérez

  • Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones

    Xavier Mulet;Gabriel Cabot;Alain A. Ocampo-Sosa;M. Angeles Domínguez

  • Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones

    Carlos Juan;Laura Zamorano;Ana Mena;Sebastián Albertí

  • Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain

    Esther Viedma;Carlos Juan;Joshi Acosta;Laura Zamorano

  • Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.

    Gabriel Cabot;Carla López-Causapé;Alain A. Ocampo-Sosa;Lea Mette Madsen Sommer

  • Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa

    Bartolomé Moyá;Laura Zamorano;Carlos Juan;Yigong Ge

Frequent Co-Authors

Antonio Oliver
Antonio Oliver Instituto de Salud Carlos III
Sebastián Albertí
Sebastián Albertí University of the Balearic Islands
Pedro Oromí
Pedro Oromí University of La Laguna
Jesús Blázquez
Jesús Blázquez Spanish National Research Council
Fe Tubau
Fe Tubau Bellvitge University Hospital
Rafael Cantón
Rafael Cantón Instituto Ramón y Cajal de Investigación Sanitaria
Germán Bou
Germán Bou University of A Coruña
Ferran Navarro
Ferran Navarro Autonomous University of Barcelona
Luis Martínez-Martínez
Luis Martínez-Martínez University of Córdoba
Teresa M. Coque
Teresa M. Coque Instituto Ramón y Cajal de Investigación Sanitaria

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open diverse career pathways. For those interested in public health, pursuing mph online programs with easy admission requirements offers a flexible way to enter the healthcare field without stringent entry barriers. These programs can complement a background in microbiology by focusing on disease prevention and health promotion.

Another unique career option is becoming a child life specialist. This role focuses on assisting children in healthcare settings, utilizing knowledge of biology and psychology, making it a meaningful pathway for those passionate about child welfare and developmental support.

For individuals concerned about past convictions, online education offers hope. The guide on what is the best degree for a convicted felon highlights degrees that foster second chances. Microbiology-related fields can be accessible through these forgiving educational paths, helping to rebuild careers in science and healthcare.

Lastly, combining microbiology with nursing can lead to specialized roles like a functional medicine nurse practitioner programs. These programs integrate holistic approaches and biological sciences, broadening career opportunities in patient-centered care and innovative treatments.

Best Scientists Citing Carlos Juan

Trending Scientists